Johnson & Johnson at Antibody Engineering 2026

Dec 13–16, 2026 San Diego, CA ~900 attendees Website

Johnson & Johnson takes part in 3 sessions at Antibody Engineering 2026 in San Diego. Its program covers animal-based antibody discovery, testing complex biologic drugs for developability, and a science talent award. Its research shows how a molecule's format shapes its physical behavior and how easily it can be developed into a medicine.

OrganizationAntibody Engineering 2026 Attendance
Johnson & Johnson
New Brunswick, NJ
Large pharma
Healthcare company whose Innovative Medicine segment develops antibodies, bispecifics and other medicines.
Talk
Sun Dec 13
2:15pm–2:45pm
Format Matters: Biophysical Characterization and Developability of Complex Biotherapeutics
How a molecule's overall shape changes whether it can be made into a drug, across many measured antibody formats.
Talk
Mon Dec 14
10:55am–11:30am
Jim Huston Science Talent Award and Presentation
Keynote Presentations - Livestream · with Xencor, Dana-Farber Cancer Institute
Chair
Tue Dec 15
8:10am–8:15am
Co-Chairs’ Remarks
Track 1: Advanced In Vivo Approaches to Antibody Discovery · with Genentech

Explore the full Antibody Engineering 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Diego. Leave your work email and we’ll be in touch.

Privacy

Download the full Antibody Engineering 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Johnson & Johnson

Tell us what you sell and we’ll find the people at Johnson & Johnson most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by Antibody Engineering & Therapeutics, its organizers or The Antibody Society. Submit a correction